
The Append Medical system is designed to prevent blood clot leakage by achieving complete LAA elimination thus reducing the risk of stroke in patients with non-valvular atrial fibrillation. Without implanting any device in the heart, Append is poised to disrupt the LAA occlusion market with a proprietary vacuum system, eradicating DRT and PDL risks while providing a transcatheter solution that universally fits the widest range of anatomies
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.